FDA Medical Device and Commercialization Strategies for Health Care Innovators
Health Care & Life Sciences Outlook: A Weekly Briefing
Description:
Cozen O’Connor invites you to attend a weekly webinar series exploring key issues impacting the health care and life sciences sector. Join us for an engaging series that will provide practical guidance and timely insights to help health care and life sciences companies stay ahead of emerging risks, regulatory developments, and industry trends.
This week's program provides an overview of regulatory pathways, commercialization considerations, and strategic planning for innovators developing medical devices in the health care sector.
Webinar Date+Time:
Thursday, September 3, 20261 PM ET | 12 PM CT | 11 AM MT | 10 AM PT
Free Continuing Legal Education Webinar - Register Now!
Credit:
1 credit hour approved in PA, NY, CA, TX, IL, and NV
and available in NJ through reciprocity. You may be able to self‑apply for credit in some other states.
Speakers:
- John Shire is Co-Chair of Health Care & Life Sciences at Cozen O’Connor. He advises innovators and health care organizations on regulatory strategy, commercialization pathways, and compliance considerations for medical device development.
- Aselle Kurmanova is Member of Cozen O’Connor. She counsels clients on FDA regulatory requirements, product development strategy, and market entry planning for emerging medical technologies.
- Danielle E. Sapega is Member of Cozen O’Connor. She focuses on regulatory compliance, commercialization strategy, and legal risk management for medical device innovators and health care companies.
By:
Cozen O'Connor, established in 1970 and ranked among the top 100 law firms in America, has 750 attorneys who help clients manage risk and make better business decisions.Upcoming Sessions in This Series:
No comments:
Post a Comment